ALPHA TRIBE

Astec LifeSciences LimitedUpdates, 31-07-2026: General Updates

31-07-2026 | 10:01 pm

Astec LifeSciences saw improved FY26 financials: Total Income rose to ₹453.22 Cr, losses narrowed to ₹80.88 Cr, and EBITDA turned positive at ₹0.54 Cr. Strong domestic sales and CDMO growth contributed. A rights issue of ₹249.35 Cr enlarged its capital base, supporting R&D and sustainability initiatives.

No comments yet. Be the first to comment!

All announcements from Astec LifeSciences Limited